Good post Oxbow and though I am into TA you are spot on...the key is the drugs work. And the pipeline is much improved-and BP has holes like Lipitor that will blast the statins like Zetia into full generic status so that something novel that works is going to rise in value to a much larger degree versus most stocks....Don't forget that commercializing acute use would be pretty quick relatively and milestones might find their way much quicker.